Health Research

Clinton Health Access Initiative (CHAI) -Training of Health Workers on Pneumonia Treatment

NPHD provided management and technically supported the CHAI team in Niger State to roll out cascaded trainings of health providers across 10 secondary health facilities. The training focused on appropriate practices for the management of childhood pneumonia, with the aim of shifting healthcare provider behaviour towards the use of pulse oximetry, oxygen therapy and Amoxicillin DT for the diagnosis and treatment of pneumonia.

The project was successfully implemented. We recruited the trainers and managed 10 training sessions in Minna, Agaie, N/Bussa and T/Magajiya and successfully trained 178 health workers, 38 doctors and pharmacists, and 140 nurses, midwives and CHEWs.

Novartis partners Medicines for Malaria Venture to develop next-generation antimalarial treatments

Novartis partners Medicines for Malaria Venture to develop next-generation antimalarial treatments

Novartis  (NVS) has announced plans to further expand its long-standing partnership with Medicines for Malaria Venture (MMV). Novartis will lead the development of antimalarial compound KAF156 with scientific and financial support from MMV in collaboration with the Bill & Melinda Gates Foundation. This agreement sets out the terms and conditions for the development of KAF156 and its future availability to patients.

“With a child dying from malaria every two minutes and the threat of drug resistance growing year-on-year,

Nigeria’s urine Malaria test, other ground-breaking healthcare solutions grab Innovation Prize for Africa

Nigeria’s urine Malaria test, Ground-breaking healthcare solutions grab the Innovation Prize for Africa (IPA) 2016 total cash Awards of US$150 000!

In a glittering ceremony that marked the five-year milestone anniversary of the Innovation Prize for Africa the landmark programme of the African Innovation Foundation (AIF) innovative healthcare solutions took pole position this year, offering ground-breaking responses to address Africa’s prevailing malaria and HIV/AIDS burdens. Out of a total of 985 applications, 10 nominees were selected, and from these Dr Valentin Agon of Benin was selected overall winner,